At the end of Q2 2026, 27 institutions reported holding Aspire Biopharma Holdin-CW27 (ASBPW) in their 13F filings, down 2 from Q1 2026. 1 opened new positions and 3 sold out. The largest holders were Saba Capital Management, L.P. ($23K), Adage Capital Partners Gp, L.L.C. ($21K) and Linden Advisors LP ($21K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
Company
Aspire Biopharma Holdin-CW27
CUSIP
738920115
Latest filing quarter
Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
Institutions
Total Value
New Positions
1
$825
Exits
3
$3K
All 13F filers, Q1 2026 → Q2 2026: 41,669 shares bought and 146,415 shares sold, net −104,746 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.